• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Proteomic analysis of micro RNA target proteins involved in cancer metastasis

Research Project

Project/Area Number 22501040
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Tumor diagnosis
Research Institution独立行政法人医薬基盤研究所

Principal Investigator

HARA Yasuhiro  独立行政法人医薬基盤研究所, 創薬基盤研究部, 研究員 (70568617)

Co-Investigator(Kenkyū-buntansha) TOMONAGA Takeshi  独立行政法人医薬基盤研究所, 創薬基盤究部, プロジェクトリーダー (80227644)
MATSUBARA Hisahiro  千葉大学, 医学(系)・研究科(研究院), 教授 (20282486)
ISHIHAMA Yasushi  京都大学, 薬学研究科(研究院), 教授 (30439244)
Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywordsプロテオミクス解析
Research Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that down-regulate gene expression and play important roles in tumorigenesis. Although a number of miRNA target proteins could be predicted, few of them have been validated experimentally and the precise mechanism of the inhibition of metastasis by miRNA has not been elucidated. Thus, we conducted a proteomic search for miRNA-target proteins. First, we focused on miR-31, recently, reported to inhibit metastasis of human breast cancer xenografts, and identification of its targets should be important for understanding the mechanism of cancer metastasis. Thus, we conducted a proteomic search for miR-31-target proteins. We over-expressed miR-31 in metastatic MDA-MB-231 human breast cancer cells using lentiviral vector and searched for differentially expressed proteins between miR-31?infected and empty vector?infected cells. Protein extracts from the cells were digested with trypsin and labeled with an isobaric tagging reagent, iTRAQ. The tryptic peptides were fractionated using a SCX column and identified by LC-MS/MS. A number of proteins with altered expression were identified by miR-31 over-expression.
Next, we selected miR-145,miR-205,miR-206,miR-335 as candidates for miRNAs involved in metastasis inhibition. We over-expressed these miRNAs in MDA-MB-231 cells using lentiviral vector and determined whether they affect cells invasion by matrigel invasion assay. Results from invasion assays showed that these miRNAs were not able to suppress cells invasion.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (5 results)

All 2010 Other

All Presentation (4 results) Remarks (1 results)

  • [Presentation] Proteomic analysis of miR-31 target proteins involved in breast cancer metastasis2010

    • Author(s)
      原康洋
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪
    • Year and Date
      2010-09-22
    • Related Report
      2010 Annual Research Report
  • [Presentation] 乳癌転移に関わるmicroRNA(miR-31)のターゲットタンパク質のプロテオーム解析2010

    • Author(s)
      原康洋
    • Organizer
      日本ヒトプロテオーム機構第8回大会
    • Place of Presentation
      東京
    • Year and Date
      2010-07-26
    • Related Report
      2010 Annual Research Report
  • [Presentation] 乳癌転移に関わるmicroRNA (miR-31)のターゲットタンパク質のプロテオーム解析2010

    • Author(s)
      原 康洋, 朝長 毅
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪
    • Related Report
      2012 Final Research Report
  • [Presentation] 乳癌転移に関わるmicroRNA (miR-31)のターゲットタンパク質のプロテオーム解析2010

    • Author(s)
      原 康洋, 朝長 毅
    • Organizer
      日本ヒトプロテオーム機構第8回大会
    • Place of Presentation
      東京
    • Related Report
      2012 Final Research Report
  • [Remarks]

    • URL

      http://www.nibio.go.jp/proteome/index.html

    • Related Report
      2010 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi